Adrucil

Active Ingredient(s): Fluorouracil, 5-FU
FDA Approved: * August 28, 1991
Pharm Company: * SICOR PHARMS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Adrucil Overview

Fluorouracil (5-FU), sold under the brand name Adrucil among others, is a medication used to treat cancer.[2] By injection into a vein it is used for colon cancer, esophageal cancer, stomach cancer, pancreatic cancer, breast cancer, and cervical cancer.[2] As a cream it is used for actinic keratosis, basal cell carcinoma, and skin warts.[3][4] When used by injection most people develop side effects.[2] Common side...

Read more Adrucil Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fluorouracil

Recent Adrucil Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fluorouracil, 5-FU
  • Cream: 0.5%, 0.50%, 1%, 4%, 5%
  • Cream, Augmented: 4%
  • Injection: 50mg/ml
  • Solution: 1%, 2%, 5%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Adrucil: (3 results)

Sorted by National Drug Code
  • 0703-3015 Adrucil 50 mg/ml Intravenous Injection by Teva Parenteral Medicines, Inc.
  • 0703-3018 Adrucil 2.5 g/50ml Intravenous Injection by Teva Parenteral Medicines, Inc.
  • 0703-3019 Adrucil 5 g/100ml Intravenous Injection by Teva Parenteral Medicines, Inc.

Other drugs which contain Fluorouracil, 5-FU or a similar ingredient: (5 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA